12:00 AM
Jun 25, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Neutrolin regulatory update

CorMedix said it received a request for additional information and data for a CE Mark application for Neutrolin to prevent catheter-related bloodstream infection and maintenance of catheter patency in hemodialysis catheters. The...

Read the full 137 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >